Belantamab Biosimilar - Research Grade

RUO belantamab mafodotin. Belantamab mafodotin is a medication for the treatment of relapsed and refractory multiple myeloma.

Detects human BCMA. This non-therapeutic antibody uses the same sequence as the therapeutic antibody Belantamab mafodotin.

GSK2857916, B-cell maturation antigen, CD269

Q02223

Human

BCMA

IgG1

Functional Assays

This monoclonal antibody was purified using multi-step affinity chromatography methods such as Protein A or G depending on the species and isotype.

5mg/mL

≤ 1.0 EU/mg as determined by the LAL method

>95% by SDS-PAGE

ICH3002

Blue ice

This biosimilar is stable when stored at 2-8°C. For longer term storage (> 3 months) it is recommended to store this antibody at -20°C or -70°C.

Sterile, preservative-free, solution in PBS. BSA and Azide free.

This biosimilar is for research use only (RUO): it is not for diagnostic or therapeutic procedures and cannot be purchased by patients.

https://ichor.bio/product/bulk-human-igg1-isotype-control-ib1-ich2254/